Back
Design Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
DSGN
Design Therapeutics, Inc.
Last Price:
$11.22
Seasonality Move:
-13.68%
7 Day Trial
ALL ACCESS PASS
$
7
Design Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 1.7% based on the past 5 years of stock performance.
-
Design Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Design Therapeutics, Inc. Stock Undervalued?The current Design Therapeutics, Inc. [DSGN] share price is $11.23. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 1.7% based on the past 5 years of stock performance.
Design Therapeutics, Inc. Stock Rating
Buy
52
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. overpriced?
-
Design Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Design Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
11.30
52-Week Low:
2.60
Prediction Charts
Market Cap:
705.8M
Price in USD:
11.23
Volume:
313.2K
Beta:
1.58
Technical Analysis
SMA50:
10.37
SMA100:
9.68
SMA200:
7.47
52-Wk Change:
196.31%
Stock Predictions
-
Is Design Therapeutics, Inc. stock public?Yes, Design Therapeutics, Inc. is a publicly traded company.
-
What is the Design Therapeutics, Inc. stock quote today?The Design Therapeutics, Inc. stock price is 11.23 USD today.
-
How to buy Design Therapeutics, Inc. stock online?You can buy Design Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 10.58 | 10.99 | 11.23 | 10.24 |
| Mar-17 | 10.98 | 11.04 | 11.09 | 10.32 |
| Mar-18 | 10.96 | 10.30 | 10.99 | 10.25 |
| Mar-19 | 10.18 | 10.26 | 10.45 | 9.95 |
| Mar-20 | 10.26 | 10.31 | 10.49 | 10.17 |
| Mar-23 | 10.51 | 10.17 | 10.61 | 9.98 |
| Mar-24 | 10.06 | 10.31 | 10.39 | 9.90 |
| Mar-25 | 10.41 | 10.73 | 10.97 | 10.41 |
| Mar-26 | 10.52 | 10.71 | 10.93 | 10.52 |
| Mar-27 | 10.68 | 10.53 | 10.80 | 10.33 |
| Mar-30 | 10.52 | 10.37 | 10.70 | 10.30 |
| Mar-31 | 10.59 | 10.64 | 11.02 | 10.55 |
| Apr-1 | 10.74 | 11.01 | 11.18 | 10.74 |
| Apr-2 | 10.78 | 11.23 | 11.30 | 10.71 |
Design Therapeutics, Inc. Earnings
Design Therapeutics, Inc. Earnings Report: Per Share Design Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Design Therapeutics, Inc. Forecast Revenue Growth
Design Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Design Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.31 per share.
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.